ANDREW MARTIN: Open Payments
NPI 1154174225 · LEESBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$274 in 12 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $144 · 2025 $274
Food & beverage: $274
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $53 |
| Exact Sciences Corporation | 2 | $41 |
| Lilly USA, LLC | 2 | $41 |
| Novo Nordisk Inc | 2 | $40 |
| ABBVIE INC. | 1 | $29 |
| Astellas Pharma US Inc | 1 | $29 |
| Novartis Pharmaceuticals Corporation | 1 | $25 |
| Agios Pharmaceuticals, Inc. | 1 | $16 |
Products named: FARXIGA, The Cologuard Plus Collection Kit, Ozempic, UBRELVY, Veozah, LEQVIO, ZEPBOUND, MOUNJARO.
Industry payments across VA — which companies pay providers there.
